Meyka Pro banner
Alumis Inc.

Alumis Inc. (ALMS) Stock Overview

Explore Alumis Inc.’s financial performance, market position, analyst ratings, and future outlook.

ALMSNASDAQ
HealthcareBiotechnology
$28.25
$1.87(7.09%)
U.S. Market opens in 36h 2m

Alumis Inc. (ALMS)

Meyka AI Score

Z

Key Financials

Market Cap3.6B
P/E Ratio-14.72
EPS (TTM)$-3.92
ROE-0.55%
Fundamental Analysis

AI Price Forecasts

1 Month$30.06
3 Months$33.68
1 Year Target$24.09

ALMS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Alumis Inc. (NASDAQ: ALMS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Alumis Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ALMS on the NASDAQ shows an RSI of 53.33, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $24.09 for the NASDAQ listing.

Key metrics behind Alumis Inc.'s NASDAQ-traded stock include a P/E ratio of -14.72 and a market capitalization of 3.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ALMS on the NASDAQ.

Price Performance (NASDAQ: ALMS)

1-Day Change
-2.42%
5-Day Change
-0.81%
1-Month Change
0.39%
3-Month Change
14.42%
6-Month Change
15.26%
Year-to-Date (YTD) Change
189.45%
1-Year Change
582.37%
3-Year Change
112.41%
5-Year Change
112.41%
All-Time (Max) Change
112.41%

Contact Information

(650) 231-6625
280 East Grand Avenue, South San Francisco, CA, 94080

Company Facts

2,230 Employees
IPO DateJun 28, 2024
CountryUS
Actively Trading

Frequently Asked Questions